Studies have found that the interaction of CCL25/CCR9 can increase the expression of MMP-2 and MMP-9, which induce tumor metastasis in a variety of cancers, such as ovarian cancer [21], prostate cancer [22], non-small cell lung cancer [23], and endometriosis [24]. The gene discussed is CCR9; the disease is ovarian carcinoma.